Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose
Hossam Qassem, ICU Clinical pharmacist at Mabaret AlAsafra Group for Medical Services, shared a post on LinkedIn:
“Day 74
Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose
Key Clinical Pearls
1. Spontaneous Brain Hemorrhage — overall stance
Routine AED prophylaxis is not recommended for all spontaneous intracranial hemorrhages.
✔ Use selectively based on:
Cortical involvement
Presence of early seizure
Large clot burden
Need for neurosurgical intervention
Evidence of significant cortical irritation on imaging
Why? No evidence AEDs prevent late seizures; unnecessary use increases neurocognitive adverse effects.
2. Intracerebral Hemorrhage (ICH) — selective prophylaxis only
Do NOT use routinely in spontaneous ICH.
✔ Consider prophylaxis when:
Lobar hematoma
Cortical involvement
Hematoma >30 mL
Intraventricular extension
Early seizure at presentation
Post-operative after hematoma evacuation
Agent of choice: Levetiracetam.
3. Subarachnoid Hemorrhage (SAH)
✔ Aneurysmal SAH = Prophylaxis recommended for 3–7 days, especially when:
High Hunt & Hess grade
Cortical irritation
IVH or hydrocephalus
EVD in place
Avoid long-term use unless seizures occur.
Preferred agent: Levetiracetam (better cognitive profile vs phenytoin).
—
4. Traumatic Brain Injury (TBI)
✔ Moderate–severe TBI = 7-day AED prophylaxis
Indications:
GCS ≤ 8
Cortical contusions
Depressed/penetrating skull fractures
Subdural/epidural hematoma
Goal: Prevent early PTS (first 7 days).
AEDs do not prevent late post-traumatic epilepsy.
5. Post-craniotomy / neurosurgical interventions
✔ Prophylaxis recommended in:
Brain tumor resections (especially supratentorial)
Cortical manipulation
Hematoma evacuation
Lobectomy
Usual duration: 7 days, longer if high epileptic potential persists.
6. Agent selection, dosing and ICU pearls
Levetiracetam (Keppra) = preferred
500–1,000 mg IV/PO q12h (adjust for renal function)
No CYP interactions
Better neurocognitive profile
Avoid routine phenytoin unless clinically required (drug interactions, toxicity, monitoring burden).
STOP at 7 days if no seizures and no ongoing risk.
7. When to avoid prophylaxis
Low-risk deep ICH (basal ganglia, thalamus)
Uncomplicated cerebellar hemorrhage
SAH with no cortical involvement and no EVD
Mild TBI without cortical injury
Avoid unnecessary therapy to reduce sedation, encephalopathy, and drug interactions.
Guideline Anchors
Neurocritical Care Society (NCS) Seizure Prophylaxis Guidelines
AHA/ASA ICH and SAH Guidelines
Brain Trauma Foundation TBI Guidelines”
Stay informed with Hemostasis Today.
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
-
Apr 16, 2026, 16:10Hamid Noori: Etiological Classification of Anemia Understanding the Root Cause
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
-
Apr 16, 2026, 15:23Ifeanyichukwu Ifechidere: Argatroban – Its ‘Rescue Mission’ in Heparin-Induced Thrombocytopenia
-
Apr 16, 2026, 14:58Early Diagnosis Can Change Everything in Hemophilia Care – WFH
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical